Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HER2 assessment in locally advanced gastric cancer: comparing the results obtained with the use of two primary tumour blocks versus those obtained with the use of all primary tumour blocks.

Histopathology·2017
Same author

Inflammatory microRNA-194 and -515 attenuate the biosynthesis of chondroitin sulfate during human intervertebral disc degeneration.

Oncotarget·2017
Same author

Soil Acidification Aggravates the Occurrence of Bacterial Wilt in South China.

Frontiers in microbiology·2017
Same author

Is the Prophylactic Use of Hepatoprotectants Necessary in Anti-Tuberculosis Treatment?

Chemotherapy·2017
Same author

Light-induced aggregation of microbial exopolymeric substances.

Chemosphere·2017
Same author

Chemical Synthesis of (+)-Ryanodine and (+)-20-Deoxyspiganthine.

ACS central science·2017

Related Experiment Video

Updated: May 29, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

5.2K

An antigen-capturing and lymph node-targeting nanoparticle for cancer immunotherapy.

Zhen Zhang1, Chen Xu2, Ningqiang Gong3

  • 1Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Key Lab of Biomedical Materials of Natural Macromolecules (Beijing University of Chemical Technology, Ministry of Education), Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing 100029, China; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, No. 11, First North Road, Zhongguancun, Beijing 100190, PR China.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|January 31, 2025
PubMed
Summary

This study presents a novel in situ cancer vaccine combining chemotherapy and immunotherapy. The developed nanomicelles effectively target lymph nodes, enhance antigen presentation, and inhibit tumor growth for improved cancer immunotherapy.

Keywords:
Antigen-capturingCancer immunotherapyImmunogenic cell deathIn situ cancer vaccineLymph-node targeting

More Related Videos

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.0K
Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

14.4K

Related Experiment Videos

Last Updated: May 29, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

5.2K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.0K
Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

14.4K

Area of Science:

  • Biomedical Engineering
  • Immunology
  • Nanotechnology

Background:

  • Cancer immunotherapy shows promise but faces challenges from immunosuppressive tumor microenvironments and low tumor cell immunogenicity.
  • Developing effective strategies to overcome these barriers is crucial for improving patient outcomes.

Purpose of the Study:

  • To develop an integrated platform for in situ cancer vaccination combining chemotherapy and immunotherapy.
  • To create targeted nanoparticles for enhanced lymph node delivery and antigen capture.

Main Methods:

  • Synthesis of amphiphilic polymers with poly-albumin-binding domains (PABD) for lymph node targeting (PABD-PGEA and PABD-PGED).
  • Loading PABD-PGEA with doxorubicin (DOX) to form DOX@PABD-PGEA nanomicelles, designed to induce immunogenic cell death (ICD).
  • Evaluation of DOX@PABD-PGEA efficacy in inhibiting tumor growth and preventing recurrence in a melanoma mouse model.

Main Results:

  • PABD-PGEA demonstrated significantly enhanced lymph node-targeting ability compared to previous strategies.
  • DOX@PABD-PGEA nanomicelles effectively inhibited tumor growth and extended survival in mice.
  • The treatment prevented tumor recurrence post-surgery by improving antigen presentation and reducing immunosuppression.

Conclusions:

  • DOX@PABD-PGEA serves as an effective antigen-capturing nanoparticle platform for in situ cancer vaccines.
  • This integrated approach enhances chemotherapy and immunotherapy, offering a promising strategy for cancer treatment.